SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-14-004043
Filing Date
2014-04-22
Accepted
2014-04-22 16:15:38
Documents
9
Period of Report
2014-06-03
Effectiveness Date
2014-04-22

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2219792zdef14a.htm DEF 14A 686031
2 G931321.JPG g931321.jpg GRAPHIC 17412
3 G37.JPG g37.jpg GRAPHIC 10803
4 G878394.JPG g878394.jpg GRAPHIC 53738
5 G1000645.JPG g1000645.jpg GRAPHIC 30564
6 G214584.JPG g214584.jpg GRAPHIC 48165
7 G433252.JPG g433252.jpg GRAPHIC 35931
8 G25692BGI001.GIF g25692bgi001.gif GRAPHIC 54308
9 G25692BGI002.GIF g25692bgi002.gif GRAPHIC 37447
  Complete submission text file 0001047469-14-004043.txt   1085720
Mailing Address 5 SYLVAN WAY SUITE 100 PARSIPPANY NJ 07054
Business Address 5 SYLVAN WAY SUITE 100 PARSIPPANY NJ 07054 973-254-3560
Pacira Pharmaceuticals, Inc. (Filer) CIK: 0001396814 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35060 | Film No.: 14776426
SIC: 2834 Pharmaceutical Preparations